Physician profile
Mark David Wasserman
NPI 1033176805
$1,109.54
in general payments reported to CMS, 2019-2025
18 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $60.64 · 2021: $158 · 2022: $39.39 · 2023: $131 · 2024: $168 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $265.76 | 2024-2025 | Dupixent |
| Pfizer INC. | $203.56 | 2019-2024 | |
| Allergan, INC. | $143.85 | 2019-2020 | |
| Genzyme Corporation | $121.85 | 2024 | |
| Abbvie INC. | $67.06 | 2021 | |
| Amgen INC. | $63.94 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.77 | 2019 | |
| Exact Sciences Corporation | $25.23 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $23.42 | 2022 | |
| Mayne Pharma Commercial LLC | $22.83 | 2021 | |
| Sumitomo Pharma America, INC. | $21.51 | 2023 | Gemtesa |
| Greenwich Biosciences, INC. | $19.05 | 2019 | |
| Glaxosmithkline, LLC. | $18.46 | 2023 | Shingrix |
| Daiichi Sankyo INC. | $16.23 | 2019 | |
| Merck Sharp & Dohme LLC | $15.97 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.92 | 2019 | |
| Organon LLC | $14.73 | 2021 | |
| Sanofi Pasteur INC. | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wasserman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.